MedPath

The Optimal Intraoperative Supplemental Oxygen Administration During Minimally Invasive Esophagectomy

Not Applicable
Conditions
Oxygenation Index
Registration Number
NCT02026739
Lead Sponsor
Tan, Lijie
Brief Summary

The study hypothesized that a relative low oxygen concentration (40%) supplemental would be advantageous to protect the pulmonary function of patients, comparied with conventional high oxygen concentration (80%). Therefore we raise this prospective randomized controlled research.

Detailed Description

Patients underwent minimally invasive esophagectomy in Zhongshan Hospital of Fudan University will be enrolled and be randomizedly assigned to low oxygen concentration (40%) supplemental or high oxygen concentration(80%) supplemental group. Intra-operative and post-operative pressure of Oxygen in Arterial Blood will be examined, and the surgical outcome will be recorded in the two groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. Clinical Staged T1-3N0M0 esophageal cancer patients or: patients who were restaged as T1-3N0M0 esophageal cancer after neo-adjuvant therapy.
  2. Patients underwent minimally invasive esophagectomy(Thoracolaparoscopic McKeown procedure).
Exclusion Criteria
  1. Patients with previous thoracic surgery history.
  2. Patients with severe Co-morbidity.
  3. Pulmonary function is abnormal in the examination before surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
The change of oxygenation indexChange from Baseline at post-operative Day1

The change of oxygenation index is an important index to indicate the pulmonary function of patients.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Division of Thoracic Surgery & Anesthesiology, Zhongshan Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Division of Thoracic Surgery & Anesthesiology, Zhongshan Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China
Hao Wang, MD
Contact
wang.hao@zs-hospital.sh.cn
Fang Fang, MD
Sub Investigator
Jing Cang, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.